Greatmark Investment Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-12,645
| Closed | -$2.58M | – | 122 |
|
2022
Q2 | $2.58M | Sell |
12,645
-4,869
| -28% | -$993K | 0.5% | 46 |
|
2022
Q1 | $3.69M | Buy |
17,514
+3,735
| +27% | +$786K | 0.61% | 36 |
|
2021
Q4 | $3.31M | Buy |
13,779
+4,448
| +48% | +$1.07M | 0.56% | 38 |
|
2021
Q3 | $2.64M | Buy |
9,331
+206
| +2% | +$58.3K | 0.49% | 41 |
|
2021
Q2 | $3.16M | Buy |
9,125
+2,780
| +44% | +$963K | 0.57% | 39 |
|
2021
Q1 | $1.78M | Buy |
6,345
+1,870
| +42% | +$523K | 0.35% | 53 |
|
2020
Q4 | $1.1M | Sell |
4,475
-322
| -7% | -$78.9K | 0.24% | 58 |
|
2020
Q3 | $1.36M | Buy |
4,797
+847
| +21% | +$240K | 0.34% | 51 |
|
2020
Q2 | $1.06M | Sell |
3,950
-1,220
| -24% | -$326K | 0.28% | 57 |
|
2020
Q1 | $1.64M | Sell |
5,170
-5
| -0.1% | -$1.58K | 0.53% | 44 |
|
2019
Q4 | $1.54M | Buy |
5,175
+680
| +15% | +$202K | 0.38% | 51 |
|
2019
Q3 | $1.05M | Buy |
4,495
+410
| +10% | +$95.5K | 0.29% | 57 |
|
2019
Q2 | $955K | Buy |
4,085
+295
| +8% | +$69K | 0.29% | 59 |
|
2019
Q1 | $896K | Buy |
3,790
+35
| +0.9% | +$8.27K | 0.28% | 56 |
|
2018
Q4 | $1.13M | Buy |
3,755
+235
| +7% | +$70.7K | 0.4% | 49 |
|
2018
Q3 | $1.24M | Buy |
3,520
+45
| +1% | +$15.9K | 0.39% | 53 |
|
2018
Q2 | $1.01M | Buy |
3,475
+155
| +5% | +$45K | 0.35% | 53 |
|
2018
Q1 | $909K | Sell |
3,320
-15
| -0.4% | -$4.11K | 0.33% | 56 |
|
2017
Q4 | $1.06M | Buy |
3,335
+950
| +40% | +$303K | 0.38% | 54 |
|
2017
Q3 | $747K | Buy |
2,385
+1,180
| +98% | +$370K | 0.29% | 61 |
|
2017
Q2 | $327K | Buy |
1,205
+200
| +20% | +$54.3K | 0.13% | 79 |
|
2017
Q1 | $275K | Sell |
1,005
-375
| -27% | -$103K | 0.11% | 83 |
|
2016
Q4 | $391K | Buy |
1,380
+75
| +6% | +$21.3K | 0.16% | 71 |
|
2016
Q3 | $409K | Buy |
1,305
+15
| +1% | +$4.7K | 0.18% | 67 |
|
2016
Q2 | $312K | Buy |
+1,290
| New | +$312K | 0.14% | 73 |
|